Fig. 8: Schematic diagram of the mechanism by which NRSN2-AS1 promotes OC progression.

NRSN2-AS1 interacts with PTK2 and protects it from MG53-mediated degradation, thereby activating the β-catenin pathway and promoting ovarian cancer progression.

NRSN2-AS1 interacts with PTK2 and protects it from MG53-mediated degradation, thereby activating the β-catenin pathway and promoting ovarian cancer progression.